Journal of the American College of Cardiology · 2018 · 51 citations · 25 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacovigilanceAnticoagulation ManagementArrhythmia PharmacotherapyAtrial FibrillationCardiovascular Drug SafetyPharmacoepidemiologyPharmacologic ManagementAtrial Flutter PharmacotherapyBleedingBleeding Risk ReductionCohort Study InvestigationManagement Of Atrial FlutterNational Health Insurance
25
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text
Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort
Emelia J. Benjamin · JAMA · 1994 · 2.6K citations
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.4K citations · Full text
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega, Eugene Braunwald, Stephen D. Wiviott et al. · New England Journal of Medicine · 2011 · 1.9K citations · Full text
Medicine, Cardiology, Pharmacology +13